Affinity Capital Advisors, LLC Adamis Pharmaceuticals Corp Transaction History

Affinity Capital Advisors, LLC

  • $515 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 11, 2023
BUY
$0.1 - $0.3 $453 - $1,360
4,535 Added 17.59%
30,315 $3,000
Q4 2022

Jan 18, 2023
BUY
$0.14 - $0.22 $672 - $1,056
4,800 Added 22.88%
25,780 $0
Q3 2022

Oct 12, 2022
BUY
$0.24 - $0.54 $1,872 - $4,212
7,800 Added 59.18%
20,980 $4,000
Q3 2021

Oct 28, 2021
BUY
$0.92 - $1.18 $12,125 - $15,552
13,180 New
13,180 $13,000

About Adamis Pharmaceuticals Corp

ADMP Quotes by TradingView
  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Affinity Capital Advisors, LLC Portfolio

Follow Affinity Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email